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Hirschsprung’s (HSCR) disease is a congenital disorder of the colon in which certain 
nerve cells are absent due to incomplete colonization of bowel with enteric neural crest 
(NC) cells, causing chronic constipation. RET gene encodes for a tyrosine kinase receptor 
and is highly implicated in the neural crest development. Mutations or genetic variants in 
RET have accounted for most of the HSCR cases. In particular, a single nucleotide 
polymorphisms (SNP, rs2435362) residing in the intron one of RET gene are 
predominantly found in HSCR, which may cause a reduced c-RET expression in patient. 
In this study, a HSCR patient carrying a risk allele T in rs2435362 of RET gene and 
exhibiting a short segment aganglionosis and atrial/ventricular septal defects (ASD/VSD) 
was selected to establish a human model for HSCR. We reprogrammed patient’s 
fibroblast cells into iPS cells by ectopic expression of four reprogramming factors. Three 
patient-specific iPS cell lines were currently obtained. They were ES-like, expressing the 
pluripotency markers and with low DNA methylation levels of CpG sites in the promoter 
regions of NANOG and OCT3/4. Importantly, they could generate teratoma comprising 
all three germ layers when they were injected in SCID mice, further corroborating the 
cells had acquired pluripotency. Subsequent differentiation experiments revealed that 
these HSCR iPS cells were able to differentiate into NC cells of a comparable capacity as 
that of the control iPS cells (IMR90). In addition, these iPS-derived NC cells were 
multipotent and could commit to both neurogenic and smooth muscle lineages under 
defined differentiation conditions. Nevertheless, in general, all the HSCR-iPS cells 
showed a lower competency to form neurons and smooth muscle cells, suggesting that 
differentiation defects of NC may represent a cause of HSCR and other NC-associated 
disorders. Taken together, these results substantiate the potential use of our patient-
specific model to study the etiology of HSCR and other NC-associated diseases. 
